Skip to content

Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00573573
Enrollment
2
Registered
2007-12-14
Start date
2007-01-31
Completion date
2009-07-31
Last updated
2009-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperparathyroidism

Keywords

PRIMARY HYPERPARATHYROIDISM, PARATHYROID NEOPLASMS, SECONDARY HYPERPARATHYROIDISM, HYPOCALCEMIA

Brief summary

A study to determine the possibility of using far infrared radiation to treat Hyperparathyroidism.

Detailed description

Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in increased levels of calcium in the blood stream, which can lead to weakening of the bones and to kidney stones. We are postulating that the non-invasive energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to stop the over secretion of the parathyroid hormones and normalize the body's metabolic functions.

Interventions

Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.

Sponsors

GAAD Medical Research Institute Inc.
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Persons with parathyroid disease

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
The primary end point is to determine the therapeutic effects of far infrared radiation on Hyperparathyroidism.2 years

Secondary

MeasureTime frame
Effect of far infrared radiation treatment on other immune deficiency diseases like thyroidism and diabetes2 years

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026